Home/Filings/4/0001612343-20-000002
4//SEC Filing

EW Healthcare Partners, L.P. 4

Accession 0001612343-20-000002

CIK 0001409269other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 6:09 PM ET

Size

17.6 KB

Accession

0001612343-20-000002

Insider Transaction Report

Form 4
Period: 2020-06-16
Transactions
  • Conversion

    Common Stock

    2020-06-16+5,191,14712,209,003 total
  • Conversion

    Common Stock

    2020-06-16+208,85312,417,856 total(indirect: See Footnote)
  • Conversion

    Series A Preferred Stock

    2020-06-16519,114.70 total
    From: 2020-06-16Common Stock (5,191,147 underlying)
  • Conversion

    Series A Preferred Stock

    2020-06-1620,885.30 total(indirect: See Footnote)
    From: 2020-06-16Common Stock (208,853 underlying)
Transactions
  • Conversion

    Series A Preferred Stock

    2020-06-1620,885.30 total(indirect: See Footnote)
    From: 2020-06-16Common Stock (208,853 underlying)
  • Conversion

    Common Stock

    2020-06-16+208,85312,417,856 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2020-06-16+5,191,14712,209,003 total
  • Conversion

    Series A Preferred Stock

    2020-06-16519,114.70 total
    From: 2020-06-16Common Stock (5,191,147 underlying)
Transactions
  • Conversion

    Common Stock

    2020-06-16+5,191,14712,209,003 total
  • Conversion

    Series A Preferred Stock

    2020-06-1620,885.30 total(indirect: See Footnote)
    From: 2020-06-16Common Stock (208,853 underlying)
  • Conversion

    Series A Preferred Stock

    2020-06-16519,114.70 total
    From: 2020-06-16Common Stock (5,191,147 underlying)
  • Conversion

    Common Stock

    2020-06-16+208,85312,417,856 total(indirect: See Footnote)
Transactions
  • Conversion

    Common Stock

    2020-06-16+208,85312,417,856 total(indirect: See Footnote)
  • Conversion

    Series A Preferred Stock

    2020-06-1620,885.30 total(indirect: See Footnote)
    From: 2020-06-16Common Stock (208,853 underlying)
  • Conversion

    Common Stock

    2020-06-16+5,191,14712,209,003 total
  • Conversion

    Series A Preferred Stock

    2020-06-16519,114.70 total
    From: 2020-06-16Common Stock (5,191,147 underlying)
Footnotes (3)
  • [F1]The shares of Series A Preferred Stock were originally purchased from the Issuer at a purchase price of $2.50 per unit (consisting of one-tenth of one share of Series A Preferred Stock and 0.75 of a Warrant, with each whole Warrant exercisable for one share of Common Stock, at an exercise price of $3.50 per share). Each share of Series A Preferred Stock converted into ten shares of Common Stock for no additional consideration.
  • [F2]Held by EW Healthcare Partners-A L.P. ("EWHP-A"). EWHP-A is an affiliated fund of EW Healthcare Partners L.P. ("EWHP"). Essex Woodlands Fund IX-GP, L.P. ("EW Fund IX GP") is the general partner of EWHP and EWHP-A. Essex Woodlands IX, LLC ("Essex IX General Partner") is the general partner of Essex IX Fund GP. Martin P. Sutter, R. Scott Barry, Ronald W. Eastman, Petri Vainio and Steve Wiggins are each a Manager of Essex IX General Partner (the "Managers"). Each of the Managers may be deemed to exercise shared voting and investment power with respect to such shares. Each of EW Fund IX GP, Essex IX General Partner and the Managers, including Mr. Barry who is a member of the Issuer's board of directors, disclaims beneficial ownership of the shares held by EWHP and EWHP-A, except to the extent of any pecuniary interests therein.
  • [F3]The Series A Preferred Stock had no expiration date.

Issuer

Venus Concept Inc.

CIK 0001409269

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001612343

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 6:09 PM ET
Size
17.6 KB